In contrast to their murine counterparts, normal human keratinocytes and human epidermoid cell lines A431 and HaCaT fail to express IL-10 mRNA and protein

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 213-223

  Teunissen, M B M ^a   Koomen, C W ^a   Jansen, J ^a   De Waal Malefyt, R ^b   Schmitt, E ^c   Van Den Wijngaard, R M J G J ^a   Das, P K ^a   Bos, J D ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MERCK RESEARCH LABORATORIES   (United States)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

IL 10; Keratinocytes; Melanocytes; Reverse transcriptase polymerase chain reaction; UVB radiation

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA;

ARTICLE; CELL LINE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; KERATINOCYTE; LANGERHANS CELL; MELANOCYTE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ULTRAVIOLET B RADIATION;

EID: 0031036131     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-900.x     Document Type: Article

References (51)

1. Luger TA, Schwarz T. Epidermal cell derived cytokines. In: Bos JD, ed. Skin immune system (SIS). Boca Raton: CRC Press, 1990; 257-91.
2. Schwarz T, Luger TA. Effect of UV irradiation on epidermal cell cytokine production. J Photochem Photobiol 1989; 4:1-13.
3. Konnikov N, Pincus SH, Dinarello CA. Elevated plasma interleukin-1 levels in humans following ultraviolet light therapy for psoriasis. J Invest Dermatol 1989; 92:235-9.
4. Urbanski A, Schwarz T, Neuner P, Krutmann J, Kirnbauer R, Köck A, Luger TA. Ultraviolet light induces increased circulating interleukin-6 in humans. J Invest Dermatol 1990; 94:808-11.
5. Ullrich SE, McIntyre BW, Rivas JM. Suppression of the immune response to alloantigen by factors released from ultravioletirradiated keratinocytes. J Immunol 1990; 145:489-98.
6. Schwarz T, Urbanska A, Gschnait F, Luger TA. Inhibition of the induction of contact hypersensitivity by a UV-mediated epidermal cytokine. J Invest Dermatol 1986; 87:289-91.
7. Jeevan A, Ullrich SE, Dizon V, Kripke ML. Supernatants from ultraviolet-irradiated keratinocytes decrease the resistance and delayed-type hypersensitivity response to Mycobacterium bovis bacillus Calmette-Guérin in mice and impair the phagocytic ability of macrophages. Photodermatol Photoimmunol Photomed 1992; 9:255-63.
8. Spits H, de Waal Malefyt R. Functional characterization of human IL-10. Int Arch Allergy Immunol 1992; 99:8-15.
9. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Ann Rev Immunol 1993; 11:165-90.
10. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 1991; 146:3444-51.
11. De Waal Malefyt R, Haanen J, Spits H et al. Interleukin 10(IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:915-24.
12. + T cell clones and resting T cells: specific inhibition of IL-2 production and proliferation. J Immunol 1993; 150:4754-65.
13. Enk AH, Katz SI. Identification and induction of keratinocyte-derived IL-10. J Immunol 1992; 149:92-95.
14. Rivas JM, Ullrich SE. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes: an essential role for keratinocyte-derived IL-10. J Immunol 1992; 149:3865-71.
15. Enk AH, Angeloni VL, Udey MC, Katz SI. Inhibition of Langerhans cell antigen-presenting function by IL-10: a role for IL-10 in induction of tolerance. J Immunol 1993; 151:2390-8.
16. Simon JC, Mosmann T, Edelbaum D, Schopf E, Bergstresser PR, Cruz Jr PD. In vivo evidence that ultraviolet B-induced suppression of allergic contact sensitivity is associated with functional inactivation of Th1 cells. Photodermatol Photoimmunol Photomed 1994; 10:206-11.
17. Enk AH, Saloga J, Becker D, Mohamadzadeh M, Knop J. Induction of hapten-specific tolerance by interleukin 10 in vivo. J Exp Med 1994; 179:1397-402.
18. Kondo S, McKenzie RC, Sauder DN. Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 1994; 103:811-4.
19. Ullrich SE. Mechanism involved in the systemic suppression of antigen-presenting cell function by UV irradiation. Keratinocytederived IL-10 modulates antigen-presenting cell function of splenicadherent cells. J Immunol 1994; 152:3410-6.
20. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE. Normal keratinizatíon in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988; 106:761-71.
21. Le Poole IC, Mutis T, Van den Wijngaard RMJGJ, Westerhof W, Ottenhoff T, De Vries RRP, Das PK. A novel, antigen-presenting function of melanocytes and its possible relationship to hypo-pigmentary disorders. J Immunol 1993; 151:7284-92.
22. Teunissen MBM, Rongen HAH, Bos JD. Function of adhesion molecules LFA-3 and ICAM-1 on human epidermal Langerhans cells in antigen-specific T cell activation. J Immunol 1994; 152:3400-9.
23. Teunissen MBM, Koomen CW, Bos JD. Intercellular adhesion molecule-3 (CD50) on human epidermal Langerhans cells participates in T-cell activation. J Invest Dermatol 1995; 104:995-8.
24. De Waal Malefyt R, Abrams J, Bennett B, Figdor C, De Vries JE. 1L-10 inhibits cytokine synthesis by human monocytes: an auto-regulatory role of IL-10 produced by monocytes. J Exp Med 1991; 174:1209-20.
25. Van Neerven RJJ, Van t'Hoff W, Ringrose JH, Jansen HM, Aalberse RC, Wierenga EA, Kapsenberg ML, T cell epitopes of house dust mite major allergen Der p II. J Immunol 1993; 151:2326-35.
26. Van Neerven RJJ, Van de Pol MM, Wierenga EA, Aalberse RC, Jansen HM, Kapsenberg ML. Peptide specificity and HLA restriction do not dictate lymphokine production by allergen-specific T-lymphocytes. Immunol 1994; 82:351-6.
27. Del Prete G, De Carli M, Almerigogna F, Grazia Giudizi M, Biagiotti R, Romagnani S. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 1993; 150:353-60.
28. Teunissen MBM, Sylva-Steenland RMR, Bos JD. Effect of low-dose ultraviolet-B radiation on the function of human T lymphocytes in vitro. Clin Exp Immunol 1993; 94:208-13.
29. Abrams JS, Roncarolo M-G, Yssel H, Andersson G, Gleich J. Silver J. Stralegies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 1992; 127:5-24.
30. Van der Poll T, Jansen J, Levi M, Ten Cate H, Ten Cate JW, Van Deventer SJH. Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med 1994; 180:1985-8.
31. Llorente L, Richaud-Patin Y, Wijdenes J et al. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur Cytokine Netw 1993; 4:421-7.
32. Schlaak JF, Schmitt E, Hüls C, Meyer zum Büschenfelde K-H, Fleischer B. A sensitive and specific bioassay for the detection of human interleukin-10. J Immunol Methods 1994; 168:49-54.
33. Pang G, Couch L, Batey R, Clancy R, Cripps A. GM-CSF, IL-1α, IL-1β, 1L-6, IL-8, IL-10. ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1α and TNF-α. Clin Exp Immunol 1994; 96:437-43.
34. Stordeur P, Schandené L. Durez P, Gérard C, Goldman M, Velu T. Spontaneous and cycloheximide-induced interleukin-10 mRNA expression in human mononuclear cells. Mol Immunol 1995; 32:233-9.
35. Kirnbauer R, Köck A, Neuner P et al. Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J Invest Dermatol 1991; 96:484-9.
36. Gallo RL, Staszewski R, Sauder DN, Knisely TL, Granstein RD. Regulation of GM-CSF and IL-3 production from the murine keratinocyte cell line PAM 212 following exposure to ultraviolet radiation. J Invest Dermatol 1991; 97:203-9.
37. Chou Q, Russell M, Birch DE, Raymond J, Bloch W. Prevention of pre-PCR mis-priming and primer dimerization improves low-copy-number amplifications. Nucleic Acid Res 1992; 20:1717-23.
38. Grewe M, Gyufko K, Krutmann J, Interleukin-10 production by cultured human keratinocytes: regulation by ultraviolet B and ultraviolet Al radiation. J Invest Dermatol 1995; 104:3-6.
39. Rivas JM, Ullrich SE, The role of IL-4, IL-10, and TNF-α in the immune suppression induced by ultraviolet radiation. J Leukoc Biol 1994; 56:769-75.
40. Young MRI, Matthews JP, Kanabrocki EL, Sothern RB, Roitman-Johnson B, Scheving LE. Circadian rhythmometry of serum interleukin-2, interleukin-10. tumor necrosis factor-α, and granulocyte-macrophage colony-stimulating factor in men. Chronobiol Int 1995; 12:19-27.
41. Nickoloff BJ, Naidu Y. Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol 1994; 30:535-46.
42. Nickoloff BJ, Fivenson DP, Kunkel SL, Strieter RM, Turka LA. Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. Clin Immunol Immunopathol 1994; 73:63-68.
43. + macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 1994; 153:5256-64.
44. Enk CD, Sredni D, Blauvelt A, Katz SI. Induction of IL-10 gene expression in human keratinocytes by UVB exposure in vivo and in vitro. J Immunol 1995; 154:4851-6.
45. Krüger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Hüls C, Blankenstein T, Diamantstein T. Expression of interleukin 10 in human melanoma. Br J Cancer 1994; 70:1182-5.
46. Mattei S, Colombo MP, Melani C, Silvani A, Parmiani G, Herlyn M. Expression of cytokine/growth factors and their receptors in human melanoma and melanocytes. Int J Cancer 1994; 56:853-7.
47. Peterseim UM, Sarkar SN, Kupper TS. Production of IL-3 by non-transformed primary neonatal murine keratinocytes: evidence for constitutive IL-3 gene expression in neonatal epidermis. Cytokine 1993; 5:240-9.
48. Kondo S, Ciarletta A, Turner KJ, Sauder DN, McKenzie RC. Failure to detect interleukin (IL)-3 mRNA or protein in human keratinocytes: antibodies to granulocyte macrophage-colony-stimulating factor or IL-6 (but not IL-3) neutralize 'IL-3' bioactivity. J Invest Dermatol 1995; 104:335-9.
49. + cells that enhance epidermal alloantigen presentation. J Immunol 1985; 134:129-37.
50. + human epidermal antigen-presenting cells by in vivo ultraviolet A, B. and C irradiation. J Am Acad Dermatol 1987; 17:792-800.
51. + antigen-presenting cells in human epidermis. J Invest Dermatol 1987; 89:113-8.